Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Divestments (2023 - 2024)

Roivant Sciences (ROIV) has disclosed Divestments for 2 consecutive years, with $185.6 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Divestments rose 290.71% year-over-year to $185.6 million, compared with a TTM value of $233.1 million through Dec 2025, changed N/A, and an annual FY2025 reading of $260.6 million, up 448.6% over the prior year.
  • Divestments was $185.6 million for Q4 2024 at Roivant Sciences, up from $47.5 million in the prior quarter.
  • Across five years, Divestments topped out at $185.6 million in Q4 2024 and bottomed at $47.5 million in Q4 2023.